James E. Flynn - Possible Member of 10% Group, 10%+ Owner at Xilio Therapeutics, Inc.

Issuer-level insider activity

Role
Possible Member of 10% Group, 10%+ Owner
Issuer ticker
XLO on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by James E. Flynn since 06 Oct 2025

Reported holdings for James E. Flynn in Xilio Therapeutics, Inc.

Form 4 holding Possible Member of 10% Group, 10%+ Owner

Xilio Therapeutics, Inc.

Security class
Common Stock
Shares / value
1,143,972
Estimated value
$949,497
Report date
26 Oct 2021
Price
$0.8300
Ownership
Through Deerfield Partners, L.P.
Form 4 holding Possible Member of 10% Group, 10%+ Owner

Xilio Therapeutics, Inc.

Security class
Common Stock
Shares / value
1,143,972
Estimated value
$949,497
Report date
26 Oct 2021
Price
$0.8300
Ownership
Through Deerfield Private Design Fund V, L.P.
Form 4 holding Possible Member of 10% Group, 10%+ Owner

Xilio Therapeutics, Inc.

Security class
Series C Preferred Stock
Shares / value
0
Estimated value
Report date
26 Oct 2021
Price
Ownership
Through Deerfield Partners, L.P.
Underlying class
Common Stock
Underlying amount
Form 4 holding Possible Member of 10% Group, 10%+ Owner

Xilio Therapeutics, Inc.

Security class
Series C Preferred Stock
Shares / value
0
Estimated value
Report date
26 Oct 2021
Price
Ownership
Through Deerfield Private Design Fund V, L.P.
Underlying class
Common Stock
Underlying amount

Transaction history for James E. Flynn in Xilio Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .